-+ 0.00%
-+ 0.00%
-+ 0.00%

CELLECTAR ENROLLS FIRST PATIENT IN CLR 125 AUGER-EMITTING RADIOCONJUGATE PHASE 1B CLINICAL TRIAL TARGETING REFRACTORY TRIPLE NEGATIVE BREAST CANCER (TNBC)

Reuters·04/14/2026 12:35:00

Please log in to view news